Real-World Data Favor Doublets in Esophageal/Gastric Cancer Real-World Data Favor Doublets in Esophageal/Gastric Cancer
Real-world data favor use of doublet chemotherapy for metastatic esophageal and gastric cancer over triplet regimens and especially over monotherapy.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Hematology